Xconomy

SEPTEMBER 19, 2016

Amid the hue and cry over the Mylan EpiPen pricing debacle , Hillary Clinton unveiled her “ Plan to Respond to Unjustified Price Hikes for Long-Available Drugs. ” Clinton’s plan calls for “dedicated oversight to protect consumers.” That dependence on price increases won’t change any time soon. It has started.”

Pricing 40

Pricing Competition Blogging Journal 40

Xconomy

AUGUST 17, 2018

We also saw a new biotech emerge in the muggy New York heat, a couple deals for new flu vaccines, and interesting developments in the complicated world of drug pricing. Both were landmarks for the companies receiving the nod, Alnylam Pharmaceuticals and Amicus Therapeutics. It’s hot out there. Stay cool with the roundup.

Pricing 52

Pricing Develop Development Venture Capital 52

Xconomy

APRIL 17, 2019

Turning Point Therapeutics raised more than $166 million in its IPO, pricing at the top of its range and putting nearly 2 million more shares into the public markets than it had initially planned. million shares at $18 apiece, raising $166.5 million before discounts, commissions, and offering expenses.

Pricing 57

Pricing Demand Marketing Develop 57

Xconomy

DECEMBER 21, 2018

Before you fly off, or drive, or simply unplug, check out our preview of what could be next year’s top clinical studies; the tumult in big pharma’s on again-off again relationship with consumer healthcare; big names on the move in the nation’s capital; and a flurry of year-end deals. Happy holidays, everyone.

Pricing 73

Pricing Sales Study News 73

Xconomy

DECEMBER 28, 2016

But as expected, the drug, from Biogen and Ionis Pharmaceuticals, is a costly one, priced at the high end of the six figure price tags often given to treatments for rare diseases with no alternative treatments. The per-injection price translates into $750,000 for.

Pricing 63

Pricing News Marketing San Diego 63

Xconomy

MAY 9, 2019

Five biotechs priced their IPOs and at least one more is coming. According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Just as last year, healthcare IPOs lead the way.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

MAY 9, 2019

billion in new capital late Thursday as it priced an initial public offering that set its market capitalization at $82.4 That price is near the lowest end of the range Uber set at $44 to $50 in the amended prospectus it filed on April 26. Ride-hailing giant Uber secured $8.1

Marketing 88

Marketing Pricing News Capital 88

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

DECEMBER 18, 2018

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Thompson to its board of directors. In Southern California, rounds that large are more often raised by life sciences companies.)

Southern California 110

Southern California San Diego Software Invest 110

Xconomy

JULY 26, 2019

What will the legacy be of Jeff Leiden, the longtime CEO of Vertex Pharmaceuticals? Vertex surprised Wall Street this week by announcing Leiden’s seven-year run will end next spring. In some ways, his legacy is already written. He steered Vertex through a crisis when its hepatitis C business was squashed by competition.

Pricing 77

Pricing Competition San Diego Patents 77

Xconomy

JUNE 16, 2016

In San Diego, the complaints often focus on the relative scarcity of venture capital and hometown VC firms. So when the San Diego Venture Group recruited Mark Suster of Los Angeles-based Upfront Ventures to give the keynote talk Tuesday night for Startup Week San Diego, more than 800 people filled a downtown auditorium.

Venture Capital 49

Venture Capital San Diego Truecar Web 49

Xconomy

MARCH 20, 2017

Japan’s Murata Manufacturing has acquired Arctic Sand Technologies of Burlington, MA, and plans to combine Arctic Sand’s low-power semiconductor technology with its San Diego-based subsidiary, Peregrine Semiconductor. The purchase price was $68 million, according to a Peregrine spokeswoman.

San Diego 63

San Diego Mobile Pricing Technology 63

Xconomy

AUGUST 25, 2017

This week saw some skirmishes in the drug price debate, new plans to expand the. Those of us who stepped outside with eclipse glasses, pin-hole projectors, or even colanders found a brief respite from the news. But developments in health policy and life sciences march onward. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 49

Pricing News Develop Development 49

Xconomy

SEPTEMBER 20, 2019

Boston, San Francisco, and a few other metro areas might dominate the US life sciences, but some weeks, all bio-related eyes are on the nation’s capital. Meanwhile, try to find someone in the federal government who isn’t involved in the drug-price debate.

Pricing 61

Pricing News Capital San Diego 61

Xconomy

OCTOBER 27, 2016

Prices for agricultural commodities such as corn, soy, and wheat are at their lowest levels in years, but investment in agricultural technology has never been better. The increase in dollars flowing to agtech comes despite commodity prices that are down 65 percent from their 2013 peak, the report says. They also queried 15 VC firms.

Venture Capital 40

Venture Capital Pricing Invest Report 40

Xconomy

JANUARY 25, 2019

Much of the math comes down to how much money you can raise for your business, and startups often look to San Francisco and Silicon Valley to find the capital they need. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Startup 101

Startup Pricing Software Capital 101

Xconomy

OCTOBER 26, 2018

In the biotech investment and research communities this week, much of the attention was turned to Europe.

Pricing 86

Pricing Conference Research Invest 86

Xconomy

JANUARY 29, 2019

The New York-based startup said Tuesday that the new funding round, which is being led by Goldman Sachs Private Capital Investing group, brings its total investment to $35 million. Billie, a monthly subscription service for shaving and body care products for women, has raised $25 million.

Product 90

Product Services Invest Pricing 90

Xconomy

MAY 16, 2018

For some migraine sufferers, bright lights or loud sounds are enough to touch off an attack. For others, stress sparks the onset of pain. Bright lights, loud sounds, stress: Migraine triggers vary from one patient to another. But a common element is the abundance of a pain-inducing protein in the blood.

Pricing 77

Pricing Develop Development San Diego 77

Xconomy

SEPTEMBER 7, 2016

San Diego-based Retrophin said that its drug, sparsentan, outperformed another drug sometimes used to manage a rare kidney disease, called focal segmental glomerulosclerosis (FSGS), in a Phase 2 clinical trial. He licensed the drug from San Diego-based Ligand Pharmaceuticals (NASDAQ: LGND ) in March 2012. to $30 apiece.

San Diego 40

San Diego Pricing Study Journal 40

Both Sides of the Table

JUNE 3, 2010

This was really a fun week at TWiVC because we decided to have an entrepreneur come and talk about raising capital rather than having a VC come on. Raised angel money from Rob Lord, Reid Hoffman, Benchmark Capital and others. Discussion: Had a long chat about PicClick , a company founded by Ryan Sit in San Diego.

Venture Capital 214

Venture Capital Startup Design S3 214

Xconomy

JUNE 12, 2019

Sunnyvale, CA-based CrowdStrike (NASDAQ: CRWD ) priced 18 million shares of common stock at $34 on Tuesday. Wednesday, and reached a near-doubling of the company’s IPO price before settling down to close at $58 for a first-day bump of more than 70 percent. That close pegged CrowdStrike’s market capitalization at $11.4

Pricing 54

Pricing Capital Marketing Venture Capital 54

Xconomy

DECEMBER 14, 2018

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. to offer competitive pricing pressure.

Patents 77

Patents Pricing Competition San Diego 77

Xconomy

JUNE 4, 2018

Inventory management is crucial to operating a successful retail operation. And as hard as it may be to believe, retailers “don’t really know what’s on the shelves,” says Sarjoun Skaff, founder and CTO of Bossa Nova Robotics.

Artificial Inteligence 69

Artificial Inteligence Pricing Product San Diego 69

Xconomy

DECEMBER 13, 2019

If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients who have a specific mutation.

Pricing 49

Pricing Southern California USC San Diego 49

Xconomy

JUNE 23, 2017

All eyes are on the nation’s capital this week, where the Senate released its version of the American Health Care Act (now called the Better Care Reconciliation Act) and the White House worked on an executive order to address drug prices. Let’s get right to it.

Pricing 52

Pricing News Capital Funding 52

Xconomy

MARCH 9, 2018

If a shopper interacts with technology in a typical grocery store, it’s usually at the very end—as they are paying for their items. That could be about to change, though.

Pricing 69

Pricing Advertising Ideas Artificial Inteligence 69

Xconomy

JUNE 22, 2018

Others that pushed their IPOs through couldn’t sell shares at the price they wanted. A total of 93 IPOs have priced as of Thursday, up 36.8 percent compared to the same time last year, according to Renaissance Capital. Seven biotech IPOs priced just this week. This year, the IPO window is wide open.

Pricing 49

Pricing Capital Draper San Diego 49

Xconomy

JANUARY 31, 2020

Black Diamond’s stock price rise shows that investors continue to be interested in companies developing kinase inhibitors for solid tumors, according to IPO research firm Renaissance Capital. In its first day of trading, the cancer drug developer watched its shares soar more than 108 percent.

Research 51

Research Pricing Activity Capital 51

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. A San Francisco investment firm, Muddy Waters Capital, announced on Sept.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

NOVEMBER 20, 2019

Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night. In turn, pricing pressure is also a concern as corporates and investors plan for the year ahead,”. Nevertheless, senior figures remain optimistic about the industry’s prospects in 2020.

Pricing 78

Pricing Invest Develop Development 78

Xconomy

AUGUST 30, 2016

Petco, the privately held pet supplies company based in San Diego, said today it led a $10 million Series A financing in Los Angeles-based Petnet, a three-year-old startup developing technology-enabled pet feeders and pet food delivery service. The deal also reflects Petco’s expanding interests in technology following the company’s $4.6-billion

San Diego 52

San Diego Los Angeles Mobile Equity 52

Xconomy

MAY 2, 2019

Beyond Meat priced its IPO Wednesday evening at $25 per share, which was the high end of its revised range. million shares at that price. The food technology company’s upsized IPO has raised $241 million to finance plans to bring its plant-based “meat” to more grocery stores and restaurants across the country.

El Segundo 82

El Segundo Pricing Technology Venture Capital 82

Xconomy

AUGUST 11, 2017

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital.

Pricing 52

Pricing News Report Competition 52

Xconomy

MAY 17, 2019

During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. But such tools only work when companies play fair.

Pricing 79

Pricing Competition Tool Marketing 79

Xconomy

MAY 1, 2019

Amazon’s stock price rose by 2.5 percent the day after it announced financial results and changes to the Prime program, while rivals Walmart (NYSE: WMT ) and Target (NYSE: TGT saw their stock prices. The Seattle e-commerce giant told analysts the move would cost around $800 million but that didn’t appear to concern investors.

Commerce 84

Commerce Pricing Startup Demand 84